United States · FDA National Drug Code directory

Clonazepam

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71610-863_26e544ba-44b8-cc65-e063-6394a90a2d64
Product NDC
71610-863
Form
TABLET
Composition / generic term
clonazepam
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Marketing category
ANDA
Marketing start / end (source format)
20180215
Source listing expiry
20261231

Source-listed ingredients

  • CLONAZEPAM — .5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 10 TABLET in 1 BOTTLE (71610-863-10) · 71610-863-10
  • 15 TABLET in 1 BOTTLE (71610-863-15) · 71610-863-15
  • 20 TABLET in 1 BOTTLE (71610-863-20) · 71610-863-20
  • 28 TABLET in 1 BOTTLE (71610-863-28) · 71610-863-28
  • 30 TABLET in 1 BOTTLE (71610-863-30) · 71610-863-30
  • 45 TABLET in 1 BOTTLE (71610-863-45) · 71610-863-45
  • 56 TABLET in 1 BOTTLE (71610-863-46) · 71610-863-46
  • 60 TABLET in 1 BOTTLE (71610-863-53) · 71610-863-53
  • 84 TABLET in 1 BOTTLE (71610-863-54) · 71610-863-54
  • 75 TABLET in 1 BOTTLE (71610-863-55) · 71610-863-55
  • 90 TABLET in 1 BOTTLE (71610-863-60) · 71610-863-60
  • 120 TABLET in 1 BOTTLE (71610-863-70) · 71610-863-70
  • 180 TABLET in 1 BOTTLE (71610-863-80) · 71610-863-80

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →